Method to improve sterility assurance in biopharmaceutic manufacturing will lead to better patient outcomes.
List view / Grid view
Cell & gene therapy
Discovery about the DNA of leukaemia cells suggests promising target for gene therapy in paediatric oncology.
Researchers have found a way to genetically modify stem cells so that cell and organ transplants are not rejected.
Changing blood stem cells into retinal ganglion cells that can migrate to the eye’s retina offers hope for cell replacement therapy.
A certain macrophage phenotype is more effective than another phenotype commonly used in cell therapy for infiltrating tumours.
New understanding of “Christchurch mutation” in the APOE gene may lead to novel Alzheimer's disease treatments.
New pathway involved in cellular protein degradation could develop LYTACs therapy and find new treatments for lysosome shortage disorders.
Researchers have engineered CAAR T cells to destroy harmful antibodies, improving NMDA receptor encephalitis treatment.
Researchers have developed a new bioreactor that can manufacture T cells faster than other technologies, which may advance immunotherapy.
Scientists have developed ExoCaps, self-healing microcapsules that are more feasible than other cell-based technologies.
New research improves patient care by finding where gene copies integrate into DNA and using lentiviral vectors.